Bharat Bhatt

Bharat Bhatt is an academic hematologist specializing in advanced multiple myeloma, with particular expertise in novel agents for relapsed and refractory disease. His clinical research has focused on the use of selinexor, daratumumab-based combinations, and emerging bispecific antibodies in heavily pretreated myeloma patients. He has contributed to our understanding of treatment sequencing and resistance mechanisms in advanced myeloma. His work at Moffitt Cancer Center spans clinical trials and translational studies.